Overview

RGD PET/MRI in Sporadic Vestibular Schwannoma

Status:
Unknown status
Trial end date:
2021-01-02
Target enrollment:
Participant gender:
Summary
The aim of this non-randomised, prospective study is to investigate the applicability and prognostic value of angiogenesis PET/MR with the radioligand 68Ga-NODAGA- E[c(RGDyK)]2 in patients with sporadic Vestibuarl Schwannomas.
Phase:
Phase 2
Details
Lead Sponsor:
Rigshospitalet, Denmark